Roza Chaireti

Roza Chaireti

Adjungerad Lektor
E-postadress: roza.chaireti@ki.se
Besöksadress: Eugeniavägen 6, plan 6, 17164 Solna
Postadress: K2 Medicin, Solna, K2 Kli med Djärv T, 171 77 Stockholm

Om mig

  • *Current position*
    Senior consultant (biträdande överläkare), Department of Haematology,
    Patient flow Coagulation and Patient flow Bone Marrow Failure and Leukaemia,
    Karolinska University Hospital
    Senior lecturer (adj.), Department of Medicine, Solna, Karolinska Institutet
    Docent/senior researcher, Department of Molecular Medicine and Surgery,
    Karolinska Institutet
    Pedagogical developer, Unit for Teaching and Learning, Karolinska Institutet
    Director of Studies, Disease and Illness 2 (Den sjuka människan 2), 4th
    term, Medical program, Karolinska Institutet (adjunct position with 60%
    clinical work and 40% teaching, Department of Medicine, Solna)
    Top third poster prizes, 2009 XXII ISTH Congress & 55th Annual SSC Meeting
    Boston (MA) USA
    ISTH/SCC Young Investigator Award (2012)
    Karolinska Institutet Foundation for Coagulation Research Scholarship (2014)
    Arosenius scholarship for Research in Haemophilia (2014)
    MD, National and Kapodistrean University of Athens, Greece, 2005
    Specialist in Internal Medicine (2012), Coagulation and Bleeding Disorders
    (2013) and Haematology (2015)
    PhD, Department of Clinical and Experimental Medicine, Linköping University,
    Thesis “Thrombin generation in different cohorts: Evaluation of the
    haemostatic potential”, 2014 https://www.avhandlingar.se/om/Roza+Chaireti/
    [1]
    Postdoc, Department of Molecular Medicine and Surgery, Karolinska Institutet
    “Global haemostatic methods following administration of bypassing agents to
    patients with haemophilia with inhibitors” 2015-2019
    Docent in Haematology, Karolinska Institutet, 2021
    Senior lecturer (lektor, adj.), Karolinska Institutet, 2022
    [1] https://www.avhandlingar.se/om/Roza+Chaireti/

Forskningsbeskrivning

  • Cancer-associated thrombosis (CAT): Studies on safety and efficacy of Direct
    Oral Anticoagulants (DOAC) in patients with solid tumours and haematological
    malignancies (treatment and prophylaxis of CAT, primary and secondary
    prophylaxis in atrial fibrillation).
    Haemostatic potential and mechanisms of thrombohaemorragic complications in
    patients with myeloproliferative neoplasms and multiple myeloma.
    Global hemostatic methods in patients with hereditary and acquired
    haemophilia with inhibitors (pediatric and adults).
    https://clinicaltrials.gov/ct2/show/NCT02453542 [1]
    Thrombotic and obstetric complications in patients with high-risk pregnancies
    (antithrombin deficiency and other thrombophilias, indication for lifelong
    anticoagulation treatment, antiphospholipid syndrome, hemoglobinopathies,
    systemic lupus erythematosus).
    Swedish registry on pregnant women with antithrombin deficiency (obstetric
    and neonatal outcomes).
    [1] https://clinicaltrials.gov/ct2/show/NCT02453542

Undervisning

Artiklar

Alla övriga publikationer

Anställningar

  • Adjungerad Lektor, Molekylär medicin och kirurgi, Karolinska Institutet, 2023-2024
  • Adjungerad Lektor, Medicin, Solna, Karolinska Institutet, 2022-2024

Nyheter från KI

Kalenderhändelser från KI